Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

KORU Medical Systems (KRMD) FCF Margin (2020 - 2025)

KORU Medical Systems (KRMD) has disclosed FCF Margin for 10 consecutive years, with 0.12% as the latest value for Q3 2025.

  • On a quarterly basis, FCF Margin rose 2467.0% to 0.12% in Q3 2025 year-over-year; TTM through Sep 2025 was 0.45%, a 487.0% increase, with the full-year FY2024 number at 4.81%, up 1510.0% from a year prior.
  • FCF Margin was 0.12% for Q3 2025 at KORU Medical Systems, up from 4.8% in the prior quarter.
  • In the past five years, FCF Margin ranged from a high of 15.21% in Q4 2022 to a low of 66.73% in Q1 2023.
  • A 5-year average of 16.51% and a median of 7.07% in 2025 define the central range for FCF Margin.
  • Peak YoY movement for FCF Margin: tumbled -5756bps in 2022, then surged 6088bps in 2024.
  • KORU Medical Systems' FCF Margin stood at 11.73% in 2021, then surged by 230bps to 15.21% in 2022, then dropped by -18bps to 12.53% in 2023, then fell by -11bps to 11.12% in 2024, then plummeted by -99bps to 0.12% in 2025.
  • Per Business Quant, the three most recent readings for KRMD's FCF Margin are 0.12% (Q3 2025), 4.8% (Q2 2025), and 7.07% (Q1 2025).